Literature DB >> 31038916

Targeting Dynamic ATP-Binding Site Features Allows Discrimination between Highly Homologous Protein Kinases.

Sujata Chakraborty, Takayuki Inukai1, Linglan Fang, Martin Golkowski, Dustin J Maly.   

Abstract

ATP-competitive inhibitors that demonstrate exquisite selectivity for specific members of the human kinome have been developed. Despite this success, the identification of highly selective inhibitors is still very challenging, and it is often not possible to rationally engineer selectivity between the ATP-binding sites of kinases, especially among closely related family members. Src-family kinases (SFKs) are a highly homologous family of eight multidomain, nonreceptor tyrosine kinases that play general and specialized roles in numerous cellular processes. The high sequence and functional similarities between SFK members make it hard to rationalize how selectivity can be gained with inhibitors that target the ATP-binding site. Here, we describe the development of a series of inhibitors that are highly selective for the ATP-binding sites of the SFKs Lyn and Hck over other SFKs. By biochemically characterizing how these selective ATP-competitive inhibitors allosterically influence the global conformation of SFKs, we demonstrate that they most likely interact with a binding pocket created by the movement of the conformationally flexible helix αC in the ATP-binding site. With a series of sequence swap experiments, we show that sensitivity to this class of selective inhibitors is due to the identity of residues that control the conformational flexibility of helix αC rather than any specific ATP-binding site interactions. Thus, the ATP-binding sites of highly homologous kinases can be discriminated by targeting heterogeneity within conformationally flexible regions.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31038916      PMCID: PMC6642640          DOI: 10.1021/acschembio.9b00214

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  39 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  Self-reporting fluorescent substrates of protein tyrosine kinases.

Authors:  Qunzhao Wang; Sean M Cahill; Michael Blumenstein; David S Lawrence
Journal:  J Am Chem Soc       Date:  2006-02-15       Impact factor: 15.419

3.  Allosteric Modulation of Src Family Kinases with ATP-Competitive Inhibitors.

Authors:  Ames C Register; Sujata Chakraborty; Dustin J Maly
Journal:  Methods Mol Biol       Date:  2017

4.  Kinobead and Single-Shot LC-MS Profiling Identifies Selective PKD Inhibitors.

Authors:  Martin Golkowski; Rama Subba Rao Vidadala; Chloe K Lombard; Hyong Won Suh; Dustin J Maly; Shao-En Ong
Journal:  J Proteome Res       Date:  2017-02-03       Impact factor: 4.466

5.  Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition.

Authors:  Jean-Baptiste Telliez; Martin E Dowty; Lu Wang; Jason Jussif; Tsung Lin; Li Li; Erick Moy; Paul Balbo; Wei Li; Yajuan Zhao; Kimberly Crouse; Caitlyn Dickinson; Peter Symanowicz; Martin Hegen; Mary Ellen Banker; Fabien Vincent; Ray Unwalla; Sidney Liang; Adam M Gilbert; Matthew F Brown; Matthew Hayward; Justin Montgomery; Xin Yang; Jonathan Bauman; John I Trujillo; Agustin Casimiro-Garcia; Felix F Vajdos; Louis Leung; Kieran F Geoghegan; Amira Quazi; Dejun Xuan; Lyn Jones; Erik Hett; Katherine Wright; James D Clark; Atli Thorarensen
Journal:  ACS Chem Biol       Date:  2016-11-10       Impact factor: 5.100

Review 6.  Kinase inhibitors: the road ahead.

Authors:  Fleur M Ferguson; Nathanael S Gray
Journal:  Nat Rev Drug Discov       Date:  2018-03-16       Impact factor: 84.694

7.  Site-specific N-terminal labeling of proteins using sortase-mediated reactions.

Authors:  Christopher S Theile; Martin D Witte; Annet E M Blom; Lenka Kundrat; Hidde L Ploegh; Carla P Guimaraes
Journal:  Nat Protoc       Date:  2013-08-29       Impact factor: 13.491

Review 8.  Src family kinases: regulation of their activities, levels and identification of new pathways.

Authors:  Evan Ingley
Journal:  Biochim Biophys Acta       Date:  2007-08-22

9.  Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways.

Authors:  Wenle Xia; Robert J Mullin; Barry R Keith; Lei-Hua Liu; Hong Ma; David W Rusnak; Gary Owens; Krystal J Alligood; Neil L Spector
Journal:  Oncogene       Date:  2002-09-12       Impact factor: 9.867

10.  Structural and Biochemical Basis for Intracellular Kinase Inhibition by Src-specific Peptidic Macrocycles.

Authors:  Saadat Aleem; George Georghiou; Ralph E Kleiner; Kip Guja; Barbara P Craddock; Agatha Lyczek; Alix I Chan; Miguel Garcia-Diaz; W Todd Miller; David R Liu; Markus A Seeliger
Journal:  Cell Chem Biol       Date:  2016-09-01       Impact factor: 8.116

View more
  6 in total

1.  In Vitro Evolution Reveals a Single Mutation as Sole Source of Src-Family Kinase C-Helix-out Inhibitor Resistance.

Authors:  Ravi K Patel; Yash K Patel; Thomas E Smithgall
Journal:  ACS Chem Biol       Date:  2020-07-15       Impact factor: 5.100

2.  How ATP-Competitive Inhibitors Allosterically Modulate Tyrosine Kinases That Contain a Src-like Regulatory Architecture.

Authors:  Linglan Fang; Jessica Vilas-Boas; Sujata Chakraborty; Zachary E Potter; Ames C Register; Markus A Seeliger; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2020-06-23       Impact factor: 5.100

Review 3.  Druggable Transient Pockets in Protein Kinases.

Authors:  Koji Umezawa; Isao Kii
Journal:  Molecules       Date:  2021-01-27       Impact factor: 4.411

4.  Parallel Chemoselective Profiling for Mapping Protein Structure.

Authors:  Zachary E Potter; Ho-Tak Lau; Sujata Chakraborty; Linglan Fang; Miklos Guttman; Shao-En Ong; Douglas M Fowler; Dustin J Maly
Journal:  Cell Chem Biol       Date:  2020-07-09       Impact factor: 8.116

5.  Norstictic Acid Is a Selective Allosteric Transcriptional Regulator.

Authors:  Julie M Garlick; Steven M Sturlis; Paul A Bruno; Joel A Yates; Amanda L Peiffer; Yejun Liu; Laura Goo; LiWei Bao; Samantha N De Salle; Giselle Tamayo-Castillo; Charles L Brooks; Sofia D Merajver; Anna K Mapp
Journal:  J Am Chem Soc       Date:  2021-06-17       Impact factor: 15.419

Review 6.  Reining in BTK: Interdomain Interactions and Their Importance in the Regulatory Control of BTK.

Authors:  Lauren E Kueffer; Raji E Joseph; Amy H Andreotti
Journal:  Front Cell Dev Biol       Date:  2021-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.